ORCL

ORCL

USD

Oracle Corporation Common Stock

$145.490-1.070 (-0.730%)

Precio en Tiempo Real

Tecnología
Software - Infrastructure
Estados Unidos

Gráfico de Precios

Loading Chart...

Métricas Clave

Métricas de Mercado
Fundamentos de la Empresa
Estadísticas de Negociación

Métricas de Mercado

Apertura

$146.560

Máximo

$148.630

Mínimo

$145.335

Volumen

0.97M

Fundamentos de la Empresa

Capitalización de Mercado

408.0B

Industria

Software - Infrastructure

País

United States

Estadísticas de Negociación

Volumen Promedio

10.55M

Bolsa

NYQ

Moneda

USD

Rango de 52 Semanas

Mínimo $114.55Actual $145.490Máximo $198.31

Informe de Análisis de IA

Última actualización: 30 abr 2025
Generado por IAFuente de Datos: Yahoo Finance, Bloomberg, SEC

ORCL: Oracle Corporation Common Stock - What's Happening and What to Watch

Stock Symbol: ORCL Generate Date: 2025-04-30 16:35:31

Alright, let's break down what's been going on with Oracle lately, looking at the news headlines, how the stock price has been acting, and what some automated predictions are hinting at.

The Recent News Buzz

Looking at the news from the past few weeks, it's a bit of a mixed bag for Oracle.

On the bright side, they've landed some significant government cloud deals, like expanding services with the U.S. Army and being chosen by the USDA. That's solid business, showing continued trust from big clients. Plus, a hospital in Canada just moved their electronic health records to Oracle Cloud, which is another win in the healthcare sector – an area where AI is apparently creating big opportunities, according to one piece of news. Oracle is also tied into that "Stargate" AI infrastructure project with some big names like SoftBank and OpenAI, which sounds pretty forward-looking.

Now for the not-so-great stuff. There was a pretty serious five-day software outage at several U.S. hospitals, reportedly caused by Oracle engineers. That's definitely a black eye and raises questions about reliability, especially in critical sectors like healthcare. On top of that, several analyst firms – Piper Sandler, Morgan Stanley, and Mizuho – have recently downgraded their ratings or lowered their price targets for Oracle's stock. That tells you the pros on Wall Street are feeling a bit less optimistic than they were before. There's also general tech news about things like Amazon pausing some data center talks and potential changes to AI chip export rules, which could impact the broader cloud and AI landscape Oracle operates in.

So, the news flow isn't all sunshine and rainbows. Good deals are happening, but there are also some notable stumbles and cautious signals from analysts.

Checking the Price Action

Now, let's look at what the stock price itself has been doing over the last month or so. If you glance at the chart data, Oracle's stock has been on a bit of a rollercoaster. It started the period around the high $130s, took a pretty sharp dive in early April, even dipping down towards the $118-$120 range. Since then, it's clawed back some of those losses, bouncing around but generally trending back upwards towards the high $130s.

As of today, the price is sitting right around that $138-$139 mark. Compared to the last month, it's recovered from the lows but is still below where it was at the very start of this 30-day window and well off its 52-week high. It's been a choppy ride, not a smooth climb or fall.

What about the immediate future? An AI model predicts a small bump today (around +0.8%), a tiny gain tomorrow (+0.03%), and then a slight dip the day after (-0.19%). This suggests the AI sees a little bit of upward momentum right now, but nothing sustained, maybe even a slight pullback soon after.

Putting It All Together: What Might This Mean?

Okay, let's try to make sense of the news, the price moves, and the AI's short-term view.

The news is quite mixed. Landing big government and healthcare cloud contracts is a definite positive, showing Oracle's continued relevance and ability to win major deals. However, the hospital outage is a serious operational issue that could dent confidence, and the analyst downgrades are a clear signal that some experts see headwinds or believe the stock was previously overvalued.

The price action reflects this uncertainty. The stock dropped significantly, likely reacting to some of these concerns or broader market tech wobbles, but it has managed to recover a good chunk of that loss. It's currently trading near the upper end of its recent range but hasn't broken out convincingly.

The AI prediction for the next couple of days is pretty muted – a small gain followed by flatness or a tiny dip. This doesn't scream "breakout coming" or "imminent crash."

So, what does this seem to suggest? Given the conflicting signals – good deals versus operational issues and analyst caution – and the choppy price action, the situation looks pretty balanced right now, maybe leaning slightly cautious due to the analyst sentiment and outage news.

For someone thinking about this stock, it doesn't look like a screaming "buy everything now" situation based purely on this data. It also doesn't look like a panic "sell everything" moment, especially since the price has bounced off recent lows and some positive business is happening.

A reasonable approach here might be to hold if you already own shares, watching closely how the company addresses the outage concerns and if analyst sentiment improves. For those looking to potentially get in, the current price is near where some analysts have recently lowered their targets to, and the AI prediction isn't showing strong upward conviction.

The Recommendation Data provided separately offers a slightly more optimistic view overall (a "balanced, promising opportunity") despite mentioning some negative technicals (MACD death cross) and fundamentals (high debt, low growth) alongside positives (near support, high ROE, analyst sentiment - though this conflicts with the news provided). That data suggests potential entry points around $140-$141, a stop loss around $126.66 (which is below the recent lows, making sense for risk management), and a take profit around $143.54 (near recent highs). While the analyst sentiment reason in that data seems inconsistent with the news we have, those price levels offer a potential framework if you were considering a trade based on the idea that the stock might bounce within its recent range.

Ultimately, the picture is complex. Positive business developments are battling negative operational news and analyst caution.

A Little Company Context

Just remember, Oracle is a giant in the software and infrastructure world. They make a ton of money from databases, enterprise software (like ERP and healthcare systems), and increasingly, cloud services. Their size and established customer base give them stability, but they also face intense competition, especially in the cloud space from players like Microsoft and Amazon. News about cloud deals, AI infrastructure, and operational reliability (like the hospital outage) are particularly important because they hit right at the core of Oracle's current and future business. The high debt mentioned in the recommendation data is also something to keep in mind for the fundamental picture.


Disclaimer: This analysis is based solely on the provided data and is for informational purposes only. It is not financial advice. Stock markets are volatile, and prices can move unexpectedly. You should always conduct your own thorough research and consider consulting with a qualified financial advisor before making any investment decisions.

Noticias Relacionadas

CNBC

Epic Systems expands EHR market share lead over Oracle Health

Epic notched its largest ever net gain in hospital market share for electronic health records, a report on Wednesday said.

Ver más
Epic Systems expands EHR market share lead over Oracle Health
CNBC

Microsoft set to report earnings after closing bell

Microsoft reports quarterly results on Wednesday for the first time since President Donald Trump's announcement of sweeping new tariffs.

Ver más
Microsoft set to report earnings after closing bell
Reuters

Cast AI secures $108 million funding to expand cloud automation

Cast AI, a Miami-based startup that helps businesses automate cloud infrastructure management, said on Wednesday it has raised $108 million in a late-stage funding round led by G2 Venture Partners and SoftBank Vision Fund 2.

Ver más
Cast AI secures $108 million funding to expand cloud automation
Reuters

Exclusive: Trump officials eye changes to Biden's AI chip export rule, sources say

The Trump administration is working on changes to a Biden-era rule that would limit global access to AI chips, including possibly doing away with its splitting the world into tiers that help determine how many advanced semiconductors a country can obtain, three sources familiar with the matter said.

Ver más
Exclusive: Trump officials eye changes to Biden's AI chip export rule, sources say
PR Newswire

New Advances in Healthcare AI Could Unlock Billions in Market Opportunity

Artificial intelligence is making deeper inroads into western healthcare, targeting the slow grind of authorizations and paperwork that bog down...

Ver más
New Advances in Healthcare AI Could Unlock Billions in Market Opportunity
Reuters

Trump to tout US investments from Nvidia, J&J, Hyundai, Toyota

CEOs and other executives from Nvidia , Johnson & Johnson , Toyota Motor , Eli Lilly and SoftBank Group are among the more than two-dozen senior business leaders slated to visit the White House on Wednesday as part of an event highlighting U.S. investments, officials told Reuters.

CNBC

Oracle engineers caused days-long software outage at U.S. hospitals

Oracle engineers triggered a five-day outage at several Community Health Systems hospitals, causing the facilities to temporarily return to paper-based records.

Predicción de IABeta

Recomendación de IA

Alcista

Actualizado el: 2 may 2025, 12:40

BajistaNeutralAlcista

62.3% Confianza

Riesgo y Negociación

Nivel de Riesgo3/5
Riesgo Medio
Adecuado Para
Conservador
Guía de Negociación

Punto de Entrada

$145.53

Toma de Ganancias

$148.42

Stop Loss

$130.96

Factores Clave

El DMI muestra una tendencia bajista (ADX:16.0, +DI:5.3, -DI:8.6), lo que sugiere precaución
El precio actual está extremadamente cerca del nivel de soporte ($146.00), lo que sugiere una fuerte oportunidad de compra
El volumen de operaciones es 5.2 veces el promedio (118,298), lo que indica una presión de compra extremadamente fuerte
El MACD 0.0281 está por encima de la línea de señal 0.0273, lo que indica un cruce alcista

Mantente Actualizado

Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.